Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer

2017871 citationsJournal Articlebronze Open Access

Authors

clinicaltrials.gov identifier: NCT00265850.

Good health and well-being

Published in: JAMA

Volume 317, Issue 23, pp. 2392-2392

Field-Weighted Citation Impact: 38.57